Screening platform for development of antibody-drug conjugates against novel targets at the National Research Council of Canada

From National Research Council Canada

DOIResolve DOI: http://doi.org/10.1158/1538-7445.AM2017-3669
AuthorSearch for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 2 
Name affiliation
  1. National Research Council Canada. Human Health Therapeutics
  2. National Research Council Canada. Information and Communication Technologies
TypeAbstract
Proceedings titleProceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC
Series titleCancer Research; Volume 77
ConferenceAmerican Association for Cancer Research Annual Meeting 2017, April 1-5, 2017, Washington, DC, USA
ISSN0008-5472
1538-7445
Article numberAbstract nr 3669
Abstract
Publication date
PublisherAmerican Association for Cancer Research
LanguageEnglish
Peer reviewedYes
NPARC number23002152
Export citationExport as RIS
Report a correctionReport a correction
Record identifierc9fb2b50-9503-4ab7-8db7-3dfd20708eb6
Record created2017-08-25
Record modified2017-08-28
Date modified: